3654 results for «370»
3654 results
Uncommon complications in NSTEMI
22 Sep 2023 – From AICT-AsiaPCR 2023
Discoversome unforeseen challenges in NSTEMI cases in this session, ranging from managing coronary air embolisms and distinguishing between inflammation and infarction to dealing with coronary aneurysms at the left main coronary artery bifurcation and addressing type 5 coronary perforation.
Advanced techniques for managing calcified lesions
22 Sep 2023 – From AICT-AsiaPCR 2023
Discover advanced strategies for tackling complex calcified lesions in this session: from innovative approaches like the 'Orbital-shock' technique to managing calcified lesions in patients with previous CABG and in-stent restenosis, and exploring calcium modification strategies tailored to specific cases, these presentations offer valuable insights into simplifying...
Complex CTO challenges
22 Sep 2023 – From AICT-AsiaPCR 2023
Gain valuable insights into overcoming CTO challenges in this session: learn how IVUS can come to the rescue in cases of main branch cut-off, discover successful recanalization techniques for right coronary artery CTOs using very long epicardial channels and explore the best approaches for managing complex...
Learning - Cardiogenic shock
22 Sep 2023 – From AICT-AsiaPCR 2023
Explore the complexities of cardiogenic shock management in this session: understand its pathophysiology, learn about the role of mechanical support (IABP, Impella, ECMO) in addition to pharmacological treatment, gather tips and tricks from expert speakers and gain insights into real-world cases.
Other valvular interventions
22 Sep 2023 – From AICT-AsiaPCR 2023
Explore innovative approaches to various valvular interventions in this session: from managing post-mitral valve replacement complications and performing balloon mitral valvotomy in patients with restenosis after mitral valve interventions to tackling calcified mitral valves and addressing unique cases like LBB pacing in isolated ccTGA with complete...
Advanced approaches to treating calcified lesions
22 Sep 2023 – From AICT-AsiaPCR 2023
Discover advanced insights into calcified lesions in this session, covering topics such as: managing double disasters, treating severe calcified left main disease, addressing complications in double vessel rotablation with left main bifurcation stenting, and using rotatripsy in OCT-guided PCI for calcified left anterior descending artery.
How to manage complications in CTO PCI
22 Sep 2023 – From AICT-AsiaPCR 2023
Explore complex CTO PCI scenarios and gain insights into complications and their solutions in this session. Topics include CTO vessel rupture after a covered stent bailout, epicardial channel perforation management, dissection from collateral tip injection, and more!
Spontaneous coronary artery disease, INOCA, MINOCA in women
21 Sep 2023 – From AICT-AsiaPCR 2023
Consult this session to better understand the causes of myocardial infarction without obstructive disease (MINOCA), to revisit ischemia with no obstructive coronary atherosclerosis (INOCA), and to broaden your understanding of spontaneous coronary artery dissection (SCAD) beyond its association with pregnancy.
Management of mitral regurgitation patients undergoing TMVI screening
13 Jan 2022
This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.
PARTNER 3: weighing the comparative costs and savings of TAVI versus SAVR in low-risk patients with severe aortic stenosis
07 Nov 2021
Professor David J. Cohen presented the results of the economic outcomes of the PARTNER 3 trial on Friday, 5 November, in the Late-Breaking Trial session of the Transcatheter Cardiovascular Therapeutics Congress 2021. Giuseppe Biondi-Zoccai provides his analysis of this study.
Author
RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure
01 Sep 2024
Nicola Ryan provides her take on the RESHAPE-HF2 trial presented by Stefan Anker at the ESC Congress 2024 in London and simultaneously published in the NEJM.
The RESHAPE-HF 2 trial is a prospective randomised control trial comparing transcatheter mitral valve repair (TEER) and guideline-directed medical therapy to guideline-directed medical...
Author
3-year Efficacy Outcomes From the Spyral Htn-on Med Pilot Study: Long Term Effect of Renal Denervation On Blood Pressure Reduction in Patients on Antihypertension Medications
22 Mar 2022
Ali Nazmi Calik provides his take on the long-term results of the SPYRAL HTN-ON MED trial which demonstrated the durable efficacy and safety of RDN in patients who are already on one to three antihypertensive drugs.
Author
The 2023 ESH Hypertension Guidelines revisit the role of renal denervation
05 Sep 2023
The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...
Author
Author
Transfemoral TAVI in the horizontal aorta
12 May 2020
Real-world case report illustrating the benefits of the Portico with FlexNav TAVI system.
